Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 24, Issue 1

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Investigational Drugs, Volume 24, Issue 1 (2015)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 24, Issue 1 (2015)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Volume 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Review

Evaluating the Phase II drugs currently under investigation for diabetic neuropathy

Ernest Adeghate (Professor) MD PhD, Erzsébet Fehér & Huba Kalász

Pages: 1-15

Published online: 29 Aug 2014

AbstractforEvaluating the Phase II drugs currently under investigation for diabetic neuropathy | Full Text | References | PDF (645.6 KB)

297 Views
4 CrossRef citations
0Altmetric

Investigational therapies for the pharmacological treatment of alcoholism

Thomas Hillemacher, Lorenzo Leggio & Annemarie Heberlein

Pages: 17-30

Published online: 28 Aug 2014

AbstractforInvestigational therapies for the pharmacological treatment of alcoholism | Full Text | References | PDF (244.5 KB)

267 Views
7 CrossRef citations
0Altmetric

CGRP antagonists and antibodies for the treatment of migraine

László Vécsei MD PhD DSc, Délia Szok (Associate Professor of Clinical Neurology) MD PhD, Anett Csáti (Clinician) MD PhD & János Tajti (Associate Professor of Clinical Neurology) MD PhD

Pages: 31-41

Published online: 15 Sep 2014

AbstractforCGRP antagonists and antibodies for the treatment of migraine | Full Text | References | PDF (365 KB)

588 Views
13 CrossRef citations
0Altmetric

Investigational drugs for visceral leishmaniasis

Shyam Sundar & Jaya Chakravarty

Pages: 43-59

Published online: 20 Nov 2014

AbstractforInvestigational drugs for visceral leishmaniasis | Full Text | References | PDF (694.4 KB)

232 Views
41 CrossRef citations
0Altmetric

Novel investigational therapies for atopic dermatitis

Kristina Sophie Ibler MD PhD & Gregor BE Jemec (Professor) MD DMSc

Pages: 61-68

Published online: 09 Sep 2014

AbstractforNovel investigational therapies for atopic dermatitis | Full Text | References | PDF (209.1 KB)

450 Views
16 CrossRef citations
0Altmetric

Histone deacetylase inhibitors in oral squamous cell carcinoma treatment

Jason Tasoulas, Constantinos Giaginis (Associate) (Assistant Professor of Human Physiology) MSc PhD, Efstratios Patsouris, Evangelos Manolis & Stamatios Theocharis

Pages: 69-78

Published online: 12 Sep 2014

AbstractforHistone deacetylase inhibitors in oral squamous cell carcinoma treatment | Full Text | References | PDF (255.8 KB)

165 Views
13 CrossRef citations
0Altmetric

Investigational cancer drugs targeting cell metabolism in clinical development

Douglas W Sborov MD, Bradley M Haverkos MD & Pamela J Harris MD

Pages: 79-94

Published online: 16 Sep 2014

AbstractforInvestigational cancer drugs targeting cell metabolism in clinical development | Full Text | References | PDF (709.2 KB)

548 Views
52 CrossRef citations
0Altmetric

Discontinued Drug Perspective

Discontinued in 2013: oncology drugs

Robert Williams (Chief Development Scientist (DDO)) PhD

Pages: 95-110

Published online: 14 Oct 2014

AbstractforDiscontinued in 2013: oncology drugs | Full Text | References | PDF (224.6 KB)

1545 Views
47 CrossRef citations
0Altmetric

Drug Evaluation

Selumetinib for the treatment of cancer

Kristen Keon Ciombor MD MSCI & Tanios Bekaii-Saab MD

Pages: 111-123

Published online: 11 Nov 2014

AbstractforSelumetinib for the treatment of cancer | Full Text | References | PDF (317.7 KB)

3483 Views
27 CrossRef citations
0Altmetric

Free Access

Farletuzumab for NSCLC: exploiting a well-known metabolic pathway for a new therapeutic strategy

Giuseppe Bronte, Francesca Lo Vullo, Gianfranco Pernice, Antonio Galvano, Eugenio Fiorentino, Giuseppe Cicero, Viviana Bazan, Christian Rolfo & Antonio Russo (Professor) MD PhD

Pages: 125-132

Published online: 03 Nov 2014

AbstractforFarletuzumab for NSCLC: exploiting a well-known metabolic pathway for a new therapeutic strategy | Full Text | References | PDF (296.4 KB)

194 Views
4 CrossRef citations
0Altmetric

The investigational drug camicinal for the treatment of gastroparesis

Kenneth Barshop & Braden Kuo MD

Pages: 133-140

Published online: 24 Oct 2014

AbstractforThe investigational drug camicinal for the treatment of gastroparesis | Full Text | References | PDF (278.3 KB)

279 Views
14 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Inflammation and Huntington’s disease- a neglected therapeutic target?

Sophie E. Field et al.

Review Article | Published online: 17 May 2024

Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status

Fernanda Karoline Vieira da Silva Torchelsen et al.

Review Article | Published online: 14 May 2024

Emerging therapies for overactive bladder: preclinical, phase I and phase II studies

Samantha Gibson et al.

Review Article | Published online: 9 May 2024

Frontotemporal dementia: from genetics to therapeutic approaches

Francesca R. Buccellato et al.

Review Article | Published online: 9 May 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.24, Iss.1, 2015)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?